公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, Wei; Chang, Ting-Tsung; Yang, Hwai-I; Peng, Cheng-Yuan; Su, Chien-Wei; TUNG-HUNG SU ; Hu, Tsung-Hui; Yu, Ming-Lung; HUNG-CHIH YANG ; Wu, Jaw-Ching | Hepatology international | 15 | 11 | |
2021 | Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C | SHIH-JER HSU ; Yu, Ming-Lung; Su, Chien-Wei; Peng, Cheng-Yuan; Chien, Rong-Nan; Lin, Hsien-Hong; Lo, Gin-Ho; Su, Wei-Wen; Kuo, Hsing-Tao; Hsu, Chao-Wei; Yang, Sien-Sing; Yang, Sheng-Shun; Tseng, Kuan-Chiao; Qin, Albert; Huang, Yi-Wen; Chuang, Wan-Long | Journal of the Formosan Medical Association = Taiwan yi zhi | 14 | 12 | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2024 | Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases | Cheng, Pin-Nan; WEN-JONE CHEN ; Hou, Charles Jia-Yin; Lin, Chih-Lin; Chang, Ming-Ling; Wang, Chia-Chi; Chang, Wei-Ting; Wang, Chao-Yung; Lin, Chun-Yen; Hung, Chung-Lieh; Peng, Cheng-Yuan; Yu, Ming-Lung; Chao, Ting-Hsing; Huang, Jee-Fu; Huang, Yi-Hsiang; Chen, Chi-Yi; Chiang, Chern-En; Lin, Han-Chieh; Li, Yi-Heng; TSUNG-HSIEN LIN ; JIA-HORNG KAO ; TZUNG-DAU WANG ; Liu, Ping-Yen; YEN-WEN WU ; CHUN-JEN LIU | Clinical and molecular hepatology | 1 | | |
2023 | TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes | Yu, Ming-Lung; CHIH-YUAN WANG ; Lee, Mei-Hsuan; Ou, Horng-Yih; Cheng, Pin-Nan; Tu, Shih-Te; Huang, Jee-Fu; Chen, Jung-Fu; Hu, Tsung-Hui; Hsu, Chih-Cheng; JIA-HORNG KAO ; Chen, Chien-Jen; Lin, Han-Chieh; Huang, Chien-Ning | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 2 | |
2022 | Three-Stage Pooled Plasma Hepatitis C Virus RNA Testing for the Identification of Acute HCV Infections in At-Risk Populations | HSIN-YUN SUN ; Chiang, Chieh; Huang, Sung-Hsi; Guo, Wen-Jin; YU-CHUNG CHUANG ; YI-CHIA HUANG ; Yang, Chia-Jui; Su, Li-Hsin; YI-TING CHEN ; Chen, Yea-Wen; Hsu, Fu-Chiang; Ho, Shu-Yuan; Liu, Wen-Chun; Su, Yi-Ching; SUI-YUAN CHANG ; Hsiao, Chin-Fu; CHIEN-CHING HUNG ; Yu, Ming-Lung | Microbiology spectrum | 9 | 6 | |